# Use of the Modified PUQE Score on Admitted Cases of Hyperemesis Gravidarum (HG) to Guide Response to Treatment

> **NCT04785911** · — · COMPLETED · sponsor: **Tasnem Abo-elouon** · enrollment: 200 (actual)

## Conditions studied

- Hyperemesis Gravidarum

## Interventions

- **DRUG:** Antiemetic Combinations

## Key facts

- **NCT ID:** NCT04785911
- **Lead sponsor:** Tasnem Abo-elouon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-05
- **Primary completion:** 2022-10-01
- **Final completion:** 2022-11-01
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2023-04-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04785911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04785911, "Use of the Modified PUQE Score on Admitted Cases of Hyperemesis Gravidarum (HG) to Guide Response to Treatment". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT04785911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*